DR-1021

DRUG2 trials

Sponsors

Duramed Research, Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

ContraceptionHealthy

Phase 3

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

CompletedNCT00362479

Duramed ResearchContraception

Start: 2006-08-31End: 2007-07-31Updated: 2013-08-21

A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

CompletedNCT00544882

Teva Branded Pharmaceutical Products R&D, Inc.Healthy

Start: 2007-10-31End: 2008-03-31Updated: 2021-11-18